NDC 73070-102-10 - Insulin Aspart
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73070-102
- Requested NDC
- 73070-102-10
- Package NDCs from labels
- 73070-102-10, 73070-102-15
- Manufacturer
- Novo Nordisk Pharma, Inc.
- Effective date
- 2023-02-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Insulin Aspart - Novo Nordisk Pharma, Inc. | Novo Nordisk Pharma, Inc. | 2023-02-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73070-102-10 | Insulin Aspart | 3 mL in 1 CARTRIDGE | INJECTION, SOLUTION | 3 | 5 | |
| 73070-102-15 | Insulin Aspart | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 73070-102-10 | ML - Milliliter | 73070-102 | 5e27b4ad-131f-4d74-815d-d93e433e2f9d | 1 | 2020-01-03 |
| 73070-102-15 | ML - Milliliter | 73070-102 | 59a10a34-1e5e-4030-b0e4-20533adb6b63 | 1 | 2020-01-03 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| QUALITY CHOICE SALINE | PLUS SOOTHING ALOE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 4ae4e88a-aaa5-4195-bedc-622fd5cd9394 | 2026-10-28 | Warnings | 451W47IQ8X |
| QUALITY CHOICE SALINE | SODIUM CHLORIDE | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f51491d8-12ad-4b1b-a171-c621bfdcc341 | 2026-10-28 | Warnings | 451W47IQ8X |
| QUALITY CHOICE Sore Throat | PHENOL | CHAIN DRUG MARKETING ASSOCIATION | c95ee086-f384-475d-ad0c-75518cb9d2fe | 2026-10-27 | Warnings | 339NCG44TV |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | PDC6A3C0OX |
| Normal Salt | SODIUM CHLORIDE | GRAXCELL PHARMACEUTICAL, LLC | f3f09817-8a38-4aa1-956b-69d9cf695074 | 2026-10-26 | Warnings | 451W47IQ8X |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Rugby Cherry Flavor | PHENOL | RUGBY LABORATORIES | 3d668c78-8130-45d4-bcb7-dddcb2fbe7a3 | 2026-10-23 | Warnings | 339NCG44TV |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| Saline | NASAL | PUBLIX SUPER MARKETS, INC | 19841567-9511-43d6-ba4e-d1e1bd3481a4 | 2026-10-22 | Warnings | 451W47IQ8X |
| PUBLIX Sore Throat Menthol Flavor | PHENOL | PUBLIX SUPER MARKETS, INC | 9296c49e-557c-43ed-9527-fcba5093a8dc | 2026-10-22 | Warnings | 339NCG44TV |
| PUBLIX Sore Throat Fast Relief Oral Anesthetic | PHENOL | PUBLIX SUPER MARKETS, INC | 89291f12-bbc3-4472-8ad3-a34485af72c9 | 2026-10-22 | Warnings | 339NCG44TV |
| Clear Eyes Cooling Redness Relief | GLYCERIN AND NAPHAZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 38d14e99-e4c8-431b-b106-578eeb38bf3c | 2026-10-15 | Warnings | PDC6A3C0OX |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | PDC6A3C0OX |
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.